Literature DB >> 20395221

Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage.

H S Nielsen1, R Steffensen, M Lund, L Egestad, L H Mortensen, A-M N Andersen, Ø Lidegaard, O B Christiansen.   

Abstract

BACKGROUND: The chance of a live birth after a diagnosis of secondary recurrent miscarriage (SRM) is reduced in patients who, prior to the miscarriages, gave birth to a boy and carry HLA class II alleles that efficiently present male-specific (H-Y) antigens to the immune system. Information about obstetric complications in births prior and subsequent to the SRM diagnosis is limited. The relations between maternal carriage of H-Y-restricting HLA, fetal sex, obstetric complications and prognosis are unknown.
METHODS: Women with unexplained SRM referred to the Danish Recurrent Miscarriage Clinic between 1986 and 2006 (n = 358) were included; 213 gave birth after the diagnosis. Controls, retrieved from the Danish National Birth Registry, were all women with singleton birth of parity 0, 1982-2005 (n = 608,068) and parity 1, 1986-2008 (n = 510,264). Cross-linkage to the National Discharge Registry identified birth complication diagnoses related to the relevant births among patients and controls.
RESULTS: The sex ratio was 1.49 in births prior to SRM and 0.76 in birth after SRM (P < 0.0001). For SRM patients with only late miscarriages (>10 weeks gestation), the corresponding sex ratios were 2.31 and 0.21. Compared with the control groups, obstetric complications were more frequent both before (39% versus 24% P <or= 0.01) and after (19% versus 14%, P = 0.01) SRM diagnosis. Births were more frequently complicated when the child was a boy (44% versus 31%, P = 0.02) before and a girl (24% versus 13%, P = 0.04) after SRM diagnosis. SRM patients with H-Y-restricting HLA class II alleles and a firstborn boy gave birth to children who weighed on average 381 g less (P = 0.006) and were born 0.9 weeks earlier (P = 0.06) and their births had more obstetric complications (P = 0.05) than patients with the same HLA alleles but a firstborn girl.
CONCLUSIONS: Obstetric complications, sex ratios in births prior and subsequent to SRM and maternal carriage of H-Y-restricting HLA class II alleles are associated parameters. Immune responses against fetal H-Y antigens initiated in the pregnancy prior to the SRM may play a causal role in SRM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395221     DOI: 10.1093/humrep/deq091

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  Chromosome Y-encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant.

Authors:  Wei Wang; Hu Huang; Michael Halagan; Cynthia Vierra-Green; Michael Heuer; Jason E Brelsford; Michael Haagenson; Richard H Scheuermann; Amalio Telenti; William Biggs; Nathaniel M Pearson; Julia Udell; Stephen Spellman; Martin Maiers; Caleb J Kennedy
Journal:  Blood Adv       Date:  2018-10-09

Review 2.  Clinical impact of H-Y alloimmunity.

Authors:  Rakesh Popli; Bita Sahaf; Hideki Nakasone; Joyce Yeuk Yu Lee; David B Miklos
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

3.  H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births.

Authors:  H S Nielsen; F Wu; Z Aghai; R Steffensen; A G van Halteren; E Spierings; O B Christiansen; D Miklos; E Goulmy
Journal:  Hum Reprod       Date:  2010-09-07       Impact factor: 6.918

Review 4.  The microbiome in reproductive health: protocol for a systems biology approach using a prospective, observational study design.

Authors:  Maria Christine Krog; Mette Elkjær Madsen; Sofie Bliddal; Zahra Bashir; Laura Emilie Vexø; Dorthe Hartwell; Luisa W Hugerth; Emma Fransson; Marica Hamsten; Fredrik Boulund; Kristin Wannerberger; Lars Engstrand; Ina Schuppe-Koistinen; Henriette Svarre Nielsen
Journal:  Hum Reprod Open       Date:  2022-03-23

5.  Interbirth intervals: Intrafamilial, intragenomic and intrasomatic conflict.

Authors:  David Haig
Journal:  Evol Med Public Health       Date:  2014-01-16

6.  The effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and individual patient data meta-analyses of randomised clinical trials.

Authors:  Pia Egerup; Jane Lindschou; Christian Gluud; Ole Bjarne Christiansen
Journal:  Syst Rev       Date:  2014-08-15

7.  Adverse pregnancy and perinatal outcome in patients with recurrent pregnancy loss: Multiple imputation analyses with propensity score adjustment applied to a large-scale birth cohort of the Japan Environment and Children's Study.

Authors:  Mayumi Sugiura-Ogasawara; Takeshi Ebara; Yasuyuki Yamada; Naoto Shoji; Taro Matsuki; Hirohisa Kano; Takahiro Kurihara; Toyonori Omori; Motohiro Tomizawa; Maiko Miyata; Michihiro Kamijima; Shinji Saitoh
Journal:  Am J Reprod Immunol       Date:  2018-12-13       Impact factor: 3.886

8.  Relationship between mean platelet volume and recurrent miscarriage: a preliminary study.

Authors:  Mehmet Yilmaz; Ilhan Bahri Delibas; Unal Isaoglu; Metin Ingec; Bunyamin Borekci; Pasa Ulug
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

9.  Inheritance of the 8.1 ancestral haplotype in recurrent pregnancy loss.

Authors:  Astrid M Kolte; Henriette S Nielsen; Rudi Steffensen; Bernard Crespi; Ole B Christiansen
Journal:  Evol Med Public Health       Date:  2015-12-16

10.  Phenome-Wide Analysis of Short- and Long-Run Disease Incidence Following Recurrent Pregnancy Loss Using Data From a 39-Year Period.

Authors:  David Westergaard; Anna Pors Nielsen; Laust Hvas Mortensen; Henriette Svarre Nielsen; Søren Brunak
Journal:  J Am Heart Assoc       Date:  2020-04-17       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.